Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Mendel Biotechnology logo — Innovative plant biotechnology solutions for a sustainable a...

Mendel Biotechnology

Innovative plant biotechnology solutions for a sustainable agricultural future with a legacy of strategic partnerships.

Founded 1997 11-50 employees Series F Total: $20.23M Agriculture, Biotechnology

General Information

Company Name Mendel Biotechnology
Founded Year 1997
Employees 11-50
Industries Agriculture, Biotechnology
Funding Stage Series F
Social

BounceWatch is an independent company data service, not affiliated with Mendel Biotechnology. To contact Mendel Biotechnology, visit mbi-holdings.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mendel Biotechnology compare?

A PDF of Mendel Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mendel Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Mendel Biotechnology

Mendel Biotechnology, Inc. is a plant biotechnology company founded in 1997 that specializes in developing genetic and chemical solutions for various agricultural markets. The company's diverse product portfolio includes offerings for biofuel feedstocks, yield enhancement, flowering, drought and freezing tolerance, disease resistance, and nutrient use efficiency. Operating in the United States, Europe, and China, Mendel Biotechnology, Inc. has established strategic partnerships with industry giants such as Monsanto Corporation, BP, and Bayer CropScience. The company's latest disclosed funding round was an $11.85M Series F investment in November 9, 2011. Despite the lack of disclosed investors in this particular round, Mendel Biotechnology, Inc. continues to build upon its legacy of strategic partnerships and remains dedicated to advancing innovative plant biotechnology solutions for a sustainable agricultural future.

Business keywords: Plant biotechnology, Agricultural markets, Genetic solutions, Chemical solutions, Biofuel feedstocks, Yield enhancement, Drought tolerance, Freezing tolerance, Disease resistance, Nutrient use efficiency, Strategic partnerships, Monsanto Corporation, BP, Bayer CropScience, Sustainable agriculture

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series F $11.85M -
09 Nov 2011
Series D $8.39M 4
Capricorn Venture Partners Ziff Brothers Investments
Capricorn Venture Partners, Ziff Brothers Investments +2
13 Jun 2007

Mendel Biotechnology Alternatives & Competitors

View All Alternatives
Mendel Biotechnology vs
Naitive Traits
Naitive Traits

Harnessing nature's power to enhance corn's resilience and yield potential through innovative native...

Venture round
Agriculture, Biotechnology
Mendel Biotechnology vs
Plastomics, Inc.
Plastomics, Inc. United States

Plastomics is developing next generation trait delivery technology that leverages the power of chlor...

Series A
26 employees
Agriculture, Biotechnology
Mendel Biotechnology vs
NewLeaf Symbiotics, Inc.
NewLeaf Symbiotics, Inc. United States

Harnessing the power of naturally occurring pink microbes to transform the world’s approach to susta...

Series D
50 employees
Agriculture, Biotechnology
View all alternatives

FAQ About Mendel Biotechnology

Innovative plant biotechnology solutions for a sustainable agricultural future with a legacy of strategic partnerships.
Mendel Biotechnology was founded in 1997.
Mendel Biotechnology operates in Agriculture and Biotechnology. Its work centres on Plant biotechnology, Agricultural markets, Genetic solutions and Chemical solutions.
Mendel Biotechnology has approximately 11-50 employees.
Mendel Biotechnology has completed 2 funding rounds, raising a total of $20.23M. The latest funding stage is Series F.
Top alternatives and competitors to Mendel Biotechnology include Naitive Traits, Plastomics, Inc., NewLeaf Symbiotics, Inc., Elicit Plant, Brandon Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mendel Biotechnology and Naitive Traits are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mendel Biotechnology, https://bouncewatch.com/company/mendel-biotechnology, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout